z-logo
open-access-imgOpen Access
Radiolabeled Tositumomab plus Fludarabine show high CR rate in Non-Hodgkin's Lymphoma
Publication year - 2005
Publication title -
cancer biology and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.166
H-Index - 113
eISSN - 1555-8576
pISSN - 1538-4047
DOI - 10.4161/cbt.4.10.2181
Subject(s) - medicine , fludarabine , follicular lymphoma , radioimmunotherapy , lymphoma , single center , regimen , oncology , rituximab , chemotherapy , non hodgkin's lymphoma , gastroenterology , antibody , immunology , monoclonal antibody , cyclophosphamide

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom